Stock listing
NASDAQ:TSRX Trius Therapeutics Inc Stock
Follow Trius Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:TSRX
$13.63 USD
Close on Sep 11, 2013 · No longer trades
- Lowest – highest close
- $3.02 – $14.10 USDSince Aug 3, 2010 · lowest Dec 6, 2010 · highest Jul 31, 2013
Delisted NASDAQ:TSRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:TSRX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Trius Therapeutics Inc on 6ix
- Decks
- 2 decks · latest Mar 25, 2013
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (March 2013) | Technical | 15 slides | Mar 25, 2013 |
| Corporate Update (January 2012) | Corporate update | 13 slides | Jan 3, 2012 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John Craig Thompson Other companies: Esperion Therapeutics, Inc. (Director · Since at least Jul 1, 2025); Anthera Pharmaceuticals Inc (President & CEO, Director · Jan 7, 2016 – Jan 5, 2018 · Past); Tetraphase Pharmaceuticals Inc (Chief Operating Officer · Feb 3, 2014 – Sep 8, 2015 · Past) | Chief Commercial Officer · Mar 8, 2012 – Sep 11, 2013 · Past |
Log in to ask 6ix AI your own questions about Trius Therapeutics Inc.